For instance, pinostilbene has been shown to delay pulmonary fibrosis and inhibit epithelial–mesenchymal transition (EMT) by directly modulating the PI3K/AKT pathway [26]. This evidence concerns the gene AKT1 and pulmonary fibrosis.